)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
SOL Group
SOL Group (SOL) investor relations material
SOL Group Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary10 Sep, 2026
Executive summary
Consolidated net sales reached €948.6 million in H1 2026, up 8.5% year-over-year, driven by organic expansion, M&A activity, and growth in both technical gases and home care segments.
EBITDA rose to €247.4 million (26.1% margin), up 12.1%, and EBIT increased to €148.8 million (15.7% margin), reflecting improved operational efficiency.
Home Care segment outperformed with 11.3% revenue growth and a 12.9% increase in patients served year-over-year.
Technical Gases segment posted a 5.5% revenue increase, maintaining stable EBITDA margins.
Growth was supported by geographic expansion, acquisitions, and an increased patient base in home care.
Financial highlights
Group revenues reached €948.6 million in H1 2026, up from €874.1 million in H1 2025.
EBITDA rose to €247.4 million (26.1% margin), and EBIT to €148.8 million (15.7% margin).
Net profit for the period was €89.9 million, up 7.6% year-over-year, with a margin at 9.5%.
EPS reached €0.991, up from €0.921 year-over-year.
CAPEX (excluding M&A) increased to €93.3 million, with total investments and acquisitions at €172.5 million in H1 2026.
Outlook and guidance
Continued focus on organic growth, targeted acquisitions, and readiness to pursue further strategic partnerships.
Emphasis on diversification and reinforcement in key markets through M&A.
Ongoing monitoring of geopolitical and energy market volatility.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from SOL Group
- FY2023 delivered stronger sales and margins, with continued growth and investment planned for 2024.SOL
H2 2023 - Q1 2026 sales grew 7.2% year-over-year, led by Home Care and international expansion.SOLQ1 2026
- Double-digit sales growth, higher profitability, and strategic acquisitions drive robust results.SOLQ4 2025
- Revenue rose 11.1% to €1,311.6M, with robust growth in both core divisions.SOLQ3 2025
- Double-digit sales and profit growth fueled by acquisitions and strong segment performance.SOLQ2 2025
- Sales up 6% to €779.6M; home care growth offsets technical gas decline, net profit down.SOLH1 2024
- 2023 sales reached €1.49B, with strong margins and leading sustainability achievements.SOLCorporate Presentation
- Q1 2025 sales rose 12.7% year-over-year, led by robust growth in both core divisions.SOLQ1 2025
- SOL Group delivered solid growth in sales and profit, led by Home Care and international markets.SOLH2 2024
Next SOL Group earnings date
Q3 202620 Nov, 2026
SOL Group
Next SOL Group earnings date
Q3 202620 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
SOL S.p.A. is an Italian company that specializes in the production and marketing of technical, industrial, pure, special, and medicinal gases. Established in 1927, the company is involved in various sectors, including healthcare, home care, biotechnologies, and the production of renewable energy. SOL offers a range of gases such as oxygen, nitrogen, argon, acetylene, carbon dioxide, hydrogen, helium, and their mixtures, catering to numerous industrial applications, scientific research, and medical uses. The company is headquartered in Monza, Italy, and its shares are listed on the Borsa Italiana.